Peptides – Arenis Medico https://arenismedico.eu Tue, 12 Jan 2021 21:42:11 +0000 es hourly 1 https://wordpress.org/?v=5.6.13 https://arenismedico.eu/wp-content/uploads/2021/02/favicons.png Peptides – Arenis Medico https://arenismedico.eu 32 32 TB-500 — 10mg Thymosin Beta-4 Acetate https://arenismedico.eu/product/tb-500-10mg-thymosin-beta-4-acetate/ Tue, 12 Jan 2021 21:40:37 +0000 https://arenismedico.eu/?post_type=product&p=575 TB-500 is a peptide fragment hormone that is primarily used in the treatment of various muscle injuries or pain caused by inflammation. There is very little official human data available for this product, however, it has been a longtime hormone used in racehorses. The primary purpose of TB-500 lies in its ability to promote the upregulation of cells in the body. Upregulation increases the cell’s sensitivity to action, specifically in proteins such as actin. This action helps to regulate inflammation in injured areas of the body as well as provide new blood vessel pathways. TB-500 possesses a very low molecular weight allowing it to travel long distances through the body, virtually to all locations. TB-500 does not have to be administered to the injured area but will find its way to all injured areas regardless of administrated location.

Side Effects

As with any injectable medication, especially peptides, the most common side effect will be skin irritation at the injected site. However, this does appear to be less common with TB-500 as compared to other peptides in terms of anecdotal reports by users. Headaches and other ill-like symptoms also appear to be very rare.

Administration

TB-500 comes in dry powder form and must be reconstituted with bacteriostatic water for administration. The most common dosing range is 2 to 2.5mg of TB-500 two times per week for approximately 4-6 weeks. Once the 4-6 weeks of use is complete and the injured area has improved, some users will reduce to one to two injections per month for injury prevention. Many users report greater muscle flexibility when using TB-500, thereby reducing further injury potential.
]]> TB-500 is a peptide fragment hormone that is primarily used in the treatment of various muscle injuries or pain caused by inflammation. There is very little official human data available for this product, however, it has been a longtime hormone used in racehorses. The primary purpose of TB-500 lies in its ability to promote the upregulation of cells in the body. Upregulation increases the cell’s sensitivity to action, specifically in proteins such as actin. This action helps to regulate inflammation in injured areas of the body as well as provide new blood vessel pathways. TB-500 possesses a very low molecular weight allowing it to travel long distances through the body, virtually to all locations. TB-500 does not have to be administered to the injured area but will find its way to all injured areas regardless of administrated location.

Side Effects

As with any injectable medication, especially peptides, the most common side effect will be skin irritation at the injected site. However, this does appear to be less common with TB-500 as compared to other peptides in terms of anecdotal reports by users. Headaches and other ill-like symptoms also appear to be very rare.

Administration

TB-500 comes in dry powder form and must be reconstituted with bacteriostatic water for administration. The most common dosing range is 2 to 2.5mg of TB-500 two times per week for approximately 4-6 weeks. Once the 4-6 weeks of use is complete and the injured area has improved, some users will reduce to one to two injections per month for injury prevention. Many users report greater muscle flexibility when using TB-500, thereby reducing further injury potential.
]]> Selank — 5mg Selank https://arenismedico.eu/product/selank-5mg-selank/ Tue, 12 Jan 2021 21:38:52 +0000 https://arenismedico.eu/?post_type=product&p=573 Selank is a synthetic derivative of the human body's naturally produced tetra-peptide Tuftsin. It is a peptide with a wide range of uses. Selank can be used as a treatment of depression, fear and general anxiety. It also reduces phsychic tension.

Side Effects

Selank has a low toxicity profile. An overdose of 500 times higher than the normal level has been proven harmless for humans. Large majority of researchers are reporting that it is a “side effect free” compound. Some believe an overdose might cause fatigue.

Administration

Selank is administered via a subcutaneous (under the skin) or intramuscular (into the muscle) injection. It comes in dry powder form to be mixed with bacteriostatic water. 200mcg per day appears to be the starting dose that can be increased up to 3mg per day. Higher doses should be divided into 2 injections per day, first taken in the morning and second later in the afternoon. The duration of Selank cycle spans from 10 days to as long as needed.
]]> Selank is a synthetic derivative of the human body's naturally produced tetra-peptide Tuftsin. It is a peptide with a wide range of uses. Selank can be used as a treatment of depression, fear and general anxiety. It also reduces phsychic tension.

Side Effects

Selank has a low toxicity profile. An overdose of 500 times higher than the normal level has been proven harmless for humans. Large majority of researchers are reporting that it is a “side effect free” compound. Some believe an overdose might cause fatigue.

Administration

Selank is administered via a subcutaneous (under the skin) or intramuscular (into the muscle) injection. It comes in dry powder form to be mixed with bacteriostatic water. 200mcg per day appears to be the starting dose that can be increased up to 3mg per day. Higher doses should be divided into 2 injections per day, first taken in the morning and second later in the afternoon. The duration of Selank cycle spans from 10 days to as long as needed.
]]> PT141 — 10mg Bremelanotide https://arenismedico.eu/product/pt141-10mg-bremelanotide/ Tue, 12 Jan 2021 21:37:02 +0000 https://arenismedico.eu/?post_type=product&p=570 PT-141, sometimes referred to as Bremelanotide is a peptide hormone that derived from Melanotan II. Melanotan II was developed for the purpose of promoting tanning, but more than 90% of all subjects during testing were found to have great increases in libido, sensitivity, performance and sexual satisfaction. These effects held true in both men and women tests subjects with the enhanced effect of male erection function being the most surprising. The effects of PT-141 on sexually related effects are approximately 50 times greater than MT2.

Side Effects

The side effects of PT-141 are somewhat limited but do appear to affect quite a few people, especially when use first begins. Nausea and vomiting are the two most common side effects. Other possible side effects of PT-141 include headache, dizziness and in some rare cases high blood pressure. Some may also find irritation at the injected area such as soreness or bruising and should rotate or search out new injection sites should this occur.

Administration

PT141 comes in dry powder form to be mixed with bacteriostatic water. PT141 is administered via a subcutaneous (under the skin) or intramuscular (into the muscle) injection. Total use in terms of dose and duration, there is no official data available, only internet conjecture.
]]> PT-141, sometimes referred to as Bremelanotide is a peptide hormone that derived from Melanotan II. Melanotan II was developed for the purpose of promoting tanning, but more than 90% of all subjects during testing were found to have great increases in libido, sensitivity, performance and sexual satisfaction. These effects held true in both men and women tests subjects with the enhanced effect of male erection function being the most surprising. The effects of PT-141 on sexually related effects are approximately 50 times greater than MT2.

Side Effects

The side effects of PT-141 are somewhat limited but do appear to affect quite a few people, especially when use first begins. Nausea and vomiting are the two most common side effects. Other possible side effects of PT-141 include headache, dizziness and in some rare cases high blood pressure. Some may also find irritation at the injected area such as soreness or bruising and should rotate or search out new injection sites should this occur.

Administration

PT141 comes in dry powder form to be mixed with bacteriostatic water. PT141 is administered via a subcutaneous (under the skin) or intramuscular (into the muscle) injection. Total use in terms of dose and duration, there is no official data available, only internet conjecture.
]]> MT-2 — 10mg Melanotan-2 https://arenismedico.eu/product/mt-2-10mg-melanotan-2/ Tue, 12 Jan 2021 21:35:23 +0000 https://arenismedico.eu/?post_type=product&p=568 Melanotan II (MT-2) functions by stimulating the receptor that produces melanin, which aids in the darkening of skin pigmentation. Because of this action, the individual will tan easier and darker than he would without the use of MT-2.

Side Effects

The most common side effect of Melanotan II is appetite suppression, but it should not be as significant as one might associate with diet or fat loss medications. Nausea and fatigue or a lightheaded feeling can also be common in some individuals. Such effects may be strong but should clear quickly. Dosing may need to be reduced should such effects occur until a more comfortable level is reached. The side effects of Melanotan II can also include the darkening of hair, although not significantly. It may also include the darkening of moles, and in some cases, may be cause to discontinue use.

Administration

Melanotan-2 is provided in dry powder form and reconstituted with bacteriostatic water. MT-2 may be injected subcutaneously (under the skin) or intramuscularly (in the muscle) with subcutaneous being the most common and convenient. Melanotan II should be kept refrigerated at all times, and should be discarded in 30 days after reconstitution. Melanotan II is typically taken at a dose of 0.5-2mg per day with 0.5-1mg being enough for most individuals who use it for tanning purposes. The same 0.5-1mg dosing is sufficient for erectile dysfunction treatment.
]]> Melanotan II (MT-2) functions by stimulating the receptor that produces melanin, which aids in the darkening of skin pigmentation. Because of this action, the individual will tan easier and darker than he would without the use of MT-2.

Side Effects

The most common side effect of Melanotan II is appetite suppression, but it should not be as significant as one might associate with diet or fat loss medications. Nausea and fatigue or a lightheaded feeling can also be common in some individuals. Such effects may be strong but should clear quickly. Dosing may need to be reduced should such effects occur until a more comfortable level is reached. The side effects of Melanotan II can also include the darkening of hair, although not significantly. It may also include the darkening of moles, and in some cases, may be cause to discontinue use.

Administration

Melanotan-2 is provided in dry powder form and reconstituted with bacteriostatic water. MT-2 may be injected subcutaneously (under the skin) or intramuscularly (in the muscle) with subcutaneous being the most common and convenient. Melanotan II should be kept refrigerated at all times, and should be discarded in 30 days after reconstitution. Melanotan II is typically taken at a dose of 0.5-2mg per day with 0.5-1mg being enough for most individuals who use it for tanning purposes. The same 0.5-1mg dosing is sufficient for erectile dysfunction treatment.
]]> Mod GRF 1-29 — 2mg Tetrasubstituted GRF 1 – 29 https://arenismedico.eu/product/mod-grf-1-29-2mg-tetrasubstituted-grf-1-29/ Tue, 12 Jan 2021 21:33:23 +0000 https://arenismedico.eu/?post_type=product&p=566 Mod GRF 1-29 is a synthetic growth hormone secretagogue from the growth hormone releasing hormone family. These compounds are based on GHRH, a natural peptide hormone that signals the release of GH from the pituitary gland. GHRH is one of two primary positive regulators of GH secretion in humans, acting together with ghrelin. Both hormones are the subjects of extensive drug development. With GHRH, though it can be synthesized as a drug product, it is not really adequate as a therapeutic agent. It is too short acting. Mod GRF 1-29 is potentially more viable. It is a shortened, modified form of GHRH that is more resistant to enzymatic cleavage. It has a longer half-life, and is a more potent agent for increasing serum GH and IGF-1 levels.

Side Effects

Common side effects to Mod GRF 1-29 include flushing, warmth, dizziness, and transient hypotension following injection. Other common side effects include sleepiness, headache, diarrhea, nausea, and abdominal pain. Also frequently reported are adverse effects typically associated with other types of growth hormone therapy, such as water retention (edema), joint pain (arthralgias), carpal tunnel syndrome, and numbness or tingling in the extremities. The subcutaneous administration of this drug may cause redness, itching, pain, or lumps at the site of injection.

Administration

Mod GRF 1-29 is provided in vials containing 2 mg of lyophylized powder. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. Injection may be subcutaneous, intramuscular, or intravenous, according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe. This reduces the total number of injections required. Recommend dosage is 100 mcg Mod GRF at a time. For maximum effect, dosing is preferably three times per day at times of low blood sugar, for example about 30 minutes before a meal, but where use is ongoing, a common use is once per day prior to sleep.
]]> Mod GRF 1-29 is a synthetic growth hormone secretagogue from the growth hormone releasing hormone family. These compounds are based on GHRH, a natural peptide hormone that signals the release of GH from the pituitary gland. GHRH is one of two primary positive regulators of GH secretion in humans, acting together with ghrelin. Both hormones are the subjects of extensive drug development. With GHRH, though it can be synthesized as a drug product, it is not really adequate as a therapeutic agent. It is too short acting. Mod GRF 1-29 is potentially more viable. It is a shortened, modified form of GHRH that is more resistant to enzymatic cleavage. It has a longer half-life, and is a more potent agent for increasing serum GH and IGF-1 levels.

Side Effects

Common side effects to Mod GRF 1-29 include flushing, warmth, dizziness, and transient hypotension following injection. Other common side effects include sleepiness, headache, diarrhea, nausea, and abdominal pain. Also frequently reported are adverse effects typically associated with other types of growth hormone therapy, such as water retention (edema), joint pain (arthralgias), carpal tunnel syndrome, and numbness or tingling in the extremities. The subcutaneous administration of this drug may cause redness, itching, pain, or lumps at the site of injection.

Administration

Mod GRF 1-29 is provided in vials containing 2 mg of lyophylized powder. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. Injection may be subcutaneous, intramuscular, or intravenous, according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe. This reduces the total number of injections required. Recommend dosage is 100 mcg Mod GRF at a time. For maximum effect, dosing is preferably three times per day at times of low blood sugar, for example about 30 minutes before a meal, but where use is ongoing, a common use is once per day prior to sleep.
]]> MGF — 5mg Mechano Growth Factor https://arenismedico.eu/product/mgf-5mg-mechano-growth-factor/ Tue, 12 Jan 2021 21:32:01 +0000 https://arenismedico.eu/?post_type=product&p=564 Mechano Growth Factor, better known as MGF, is a splice variant of Insulin-Like Growth Factor-1 (IGF-1). This hormone is largely responsible for the healing and building of damaged muscle tissue post exercise or any other activity that causes damage to the muscle tissue. The splice to MGF activates satellite cells causing the growth of new muscle fibers in the body. Further, the presence of MGF increases the body’s rate of protein synthesis. This will cause the body to increase muscle size and more importantly repair existing damaged muscle. The recovery factor associated with MGF is without question the most important and beneficial aspect of the hormone.

Side Effects

Pain or irritation at the injected area is the most common complaint, which normally refers to a sore or itchy feeling at the injected site.

Administration

MGF is an injectable peptide that is administered with an insulin needle directly into the muscle(s) immediately after training. 200mcg per injection is the normal or standard dose for most and is normally used for no more than four weeks. Users who surpass four weeks of use may find the benefits quickly fall due to an adaption. MGF is found in freeze-dried form and mixed with a sterile solution and must remain refrigerated once reconstituted. MGF should remain stable and potent for up to six months post-mixing. When used for physique- or performanceenhancing purposes, Regular MGF is usually administered at a dosage of 50-200 meg. This is generally given via IM injection(s) once daily, immediately following exercise in the muscle(s) trained. Regular MGF is typically taken on training days only, but as many as 5-6 days per week. Cycles of MGF usually last 2-3 months, though longer programs are not uncommon.
]]> Mechano Growth Factor, better known as MGF, is a splice variant of Insulin-Like Growth Factor-1 (IGF-1). This hormone is largely responsible for the healing and building of damaged muscle tissue post exercise or any other activity that causes damage to the muscle tissue. The splice to MGF activates satellite cells causing the growth of new muscle fibers in the body. Further, the presence of MGF increases the body’s rate of protein synthesis. This will cause the body to increase muscle size and more importantly repair existing damaged muscle. The recovery factor associated with MGF is without question the most important and beneficial aspect of the hormone.

Side Effects

Pain or irritation at the injected area is the most common complaint, which normally refers to a sore or itchy feeling at the injected site.

Administration

MGF is an injectable peptide that is administered with an insulin needle directly into the muscle(s) immediately after training. 200mcg per injection is the normal or standard dose for most and is normally used for no more than four weeks. Users who surpass four weeks of use may find the benefits quickly fall due to an adaption. MGF is found in freeze-dried form and mixed with a sterile solution and must remain refrigerated once reconstituted. MGF should remain stable and potent for up to six months post-mixing. When used for physique- or performanceenhancing purposes, Regular MGF is usually administered at a dosage of 50-200 meg. This is generally given via IM injection(s) once daily, immediately following exercise in the muscle(s) trained. Regular MGF is typically taken on training days only, but as many as 5-6 days per week. Cycles of MGF usually last 2-3 months, though longer programs are not uncommon.
]]> Ipamorelin — 5mg Hormone Secretagogue https://arenismedico.eu/product/ipamorelin-5mg-hormone-secretagogue/ Tue, 12 Jan 2021 21:30:26 +0000 https://arenismedico.eu/?post_type=product&p=562 Ipamorelin is highly selective for the stimulation of growth hormone release. This means minimal spillover effects on other systems. For starters, ipamorelin has been shown to only slightly increase ACTH (adrenocorticotropic hormone) and cortisol levels. Drugs of the GHRP class often mimic ghrelin's tendency to strongly stimulate hunger, which can be problematic while dieting. This makes Ipamorelin more practical for this purpose. Ipamorelin is a GHRP (Growth Hormone Releasing Peptide) that is considered one of the most side effect friendly of the GHRP hormones.

Side Effects

Common side effects to ipamorelin include flushing, sweating, headache, increased Gl motility, and sleepiness. Also frequently reported are adverse effects typically associated with other types of growth hormone therapy, such as water retention (edema), joint pain (arthralgias), carpal tunnel syndrome, and numbness or tingling in the extremities. The subcutaneous administration of this drug may cause redness, itching, pain, or lumps at the site of injection. Injection site redness and discomfort is sometimes reported with intramuscular injection as well. Ipamorelin may reduce insulin sensitivity and raise blood sugar levels. This may occur in individuals without preexisting diabetes or impaired glucose tolerance. There are no estrogenic side effects of Ipamorelin. Gynecomastia and water retention cannot occur. However, slight water retention can occur in early stages. There are no androgenic side effects of Ipamorelin, Acne, hair loss or virilization symptoms in women does not occur. There are no known cardiovascular side effects of Ipamorelin. Many users report improved cardiovascular health. Ipamorelin will not suppress natural testosterone production. Ipamorelin is not toxic to the liver at any dose.

Administration

Ipamorelin is supplied in dry powder form and is reconstituted with bacteriostatic water. Once reconstituted it needs to be kept refrigerated at all times. Ipamorelin can be injected intramuscularly (in the muscle) or subcutaneously (under the skin). Most will find subcutaneously the easiest since the medication is normally administered 2-3 times per day. A small insulin syringe will suffice. Dosing ranges for Ipamorelin normally fall in the 200-300mcg with a frequency of 2-3 times per day.
]]> Ipamorelin is highly selective for the stimulation of growth hormone release. This means minimal spillover effects on other systems. For starters, ipamorelin has been shown to only slightly increase ACTH (adrenocorticotropic hormone) and cortisol levels. Drugs of the GHRP class often mimic ghrelin's tendency to strongly stimulate hunger, which can be problematic while dieting. This makes Ipamorelin more practical for this purpose. Ipamorelin is a GHRP (Growth Hormone Releasing Peptide) that is considered one of the most side effect friendly of the GHRP hormones.

Side Effects

Common side effects to ipamorelin include flushing, sweating, headache, increased Gl motility, and sleepiness. Also frequently reported are adverse effects typically associated with other types of growth hormone therapy, such as water retention (edema), joint pain (arthralgias), carpal tunnel syndrome, and numbness or tingling in the extremities. The subcutaneous administration of this drug may cause redness, itching, pain, or lumps at the site of injection. Injection site redness and discomfort is sometimes reported with intramuscular injection as well. Ipamorelin may reduce insulin sensitivity and raise blood sugar levels. This may occur in individuals without preexisting diabetes or impaired glucose tolerance. There are no estrogenic side effects of Ipamorelin. Gynecomastia and water retention cannot occur. However, slight water retention can occur in early stages. There are no androgenic side effects of Ipamorelin, Acne, hair loss or virilization symptoms in women does not occur. There are no known cardiovascular side effects of Ipamorelin. Many users report improved cardiovascular health. Ipamorelin will not suppress natural testosterone production. Ipamorelin is not toxic to the liver at any dose.

Administration

Ipamorelin is supplied in dry powder form and is reconstituted with bacteriostatic water. Once reconstituted it needs to be kept refrigerated at all times. Ipamorelin can be injected intramuscularly (in the muscle) or subcutaneously (under the skin). Most will find subcutaneously the easiest since the medication is normally administered 2-3 times per day. A small insulin syringe will suffice. Dosing ranges for Ipamorelin normally fall in the 200-300mcg with a frequency of 2-3 times per day.
]]> IGF-1 LR3 — 1mg Insulin-Like Growth Factor-1, Long R3 https://arenismedico.eu/product/igf-1-lr3-1mg-insulin-like-growth-factor-1-long-r3/ Tue, 12 Jan 2021 21:28:45 +0000 https://arenismedico.eu/?post_type=product&p=560 IGF-I is an important hormone for human development. Its levels are especially high during childhood and adolescence, where it supports linear growth, as well as the growth of nearly all body tissues. Serum IGF-I levels decline greatly in adulthood, though remain substantial throughout life. This hormone will continue to play important roles in metabolism and physiology, including the support of skeletal muscle mass and strength. IGF-I has several key anabolic/anti-catabolic activities. It supports the synthesis of new muscle protein, satellite cell activity, and the incorporation of new nuclei into muscle cells. It is also noted for reducing the activity of both p27Kip1 and myostatin, which are two powerful inhibitors of muscle growth. As such, IGF-I is regarded as possessing both strong anabolic and anti-catabolic properties.

Side Effects

The most common adverse reaction to Long(R3)-IGF-l is hypoglycemia. Signs of mild to moderate hypoglycemia include hunger, drowsiness, blurred vision, depressive mood, dizziness, sweating, palpitation, tremor, restlessness, tingling in the hands, feet, lips, or tongue, lightheadedness, inability to concentrate, headache, sleep disturbances, anxiety, slurred speech, irritability, abnormal behavior, unsteady movement, and personality changes. If any of these warning signs should occur, one should immediately consume a food or drink containing simple sugars such as a candy bar or carbohydrate drink. Signs of severe hypoglycemia include disorientation, seizure, and unconsciousness. Severe hypoglycemia can lead to death and requires immediate emergency medical attention. Note that in some cases the symptoms of hypoglycemia can be mistaken for drunkenness. Long(R3)-IGF-l should never be taken before sleep or in higher than recommended doses. A meal or snack must be consumed within 20 minutes (before or after) of administration. The subcutaneous administration of Long(R3)-IGF-l may cause redness, itching, or bruising at the site of injection. It may also cause a localized increase of adipose tissue, which may be compounded by the repeated administration at the same site of injection. For these reasons, intramuscular injection is generally preferred with this substance. Other potential adverse reactions to Long(R3)-IGF-l include joint pain, growth of the tonsils, snoring, headache, dizziness, convulsions, vomiting, ear pain, hearing loss, and hypertrophy of the thymus gland. Long(R3)-IGF-l can stimulate the growth of internal organs. Enlargement of the kidney, spleen, and heart were all noted in studies with recombinant IGF-I therapy. Elevations in cholesterol and triglycerides were also observed.The overall relationship between Long(R3)-IGF-I use and cardiac changes remains unclear.Thickening of facial soft tissues is also possible, and should be monitored. The abuse of Long(R3)-IGF-l may cause acromegaly, which is characterized by a visible thickening of the bones, most notably the feet, forehead, hands, jaw, and elbows.

Administration

When used for physique- or performance-enhancing purposes, Long(R3)-IGF-l is primarily given by intramuscular injection. A dosage of 20-80 meg daily is most commonly used. This is given in one application, usually earlier in the day. A meal with sufficient carbohydrate content is consumed within 20 minutes of injection to help reduce the likelihood of hypoglycemia. Long(R3)-IGF-l is often injected into the muscle that will be trained that day, in an effort to support site-specific growth. However, the efficacy of this practice remains unclear. It is generally advised to taper-up the dosage of Long(R3)-IGF-l.The user often begins on the low end of the dosage range (20 meg), and increases the amount by 5-10 meg every 3-4 days, until a desired stable dosage is reached. This practice can help acclimate the user to the effects of Long(R3)-IGF-l, especially its potential blood-sugarlowering properties (see: Side Effects). Cycles of Long(R3)-IGF-l usually last 30-40 days. Beyond this, there is some concern about desensitization to its anabolic effects. After each cycle, a break of at least 4-6 weeks is usually advised. This drug has not been subject to extensive human testing, however. Likewise, its potential for desensitization has not been clearly characterized.
]]> IGF-I is an important hormone for human development. Its levels are especially high during childhood and adolescence, where it supports linear growth, as well as the growth of nearly all body tissues. Serum IGF-I levels decline greatly in adulthood, though remain substantial throughout life. This hormone will continue to play important roles in metabolism and physiology, including the support of skeletal muscle mass and strength. IGF-I has several key anabolic/anti-catabolic activities. It supports the synthesis of new muscle protein, satellite cell activity, and the incorporation of new nuclei into muscle cells. It is also noted for reducing the activity of both p27Kip1 and myostatin, which are two powerful inhibitors of muscle growth. As such, IGF-I is regarded as possessing both strong anabolic and anti-catabolic properties.

Side Effects

The most common adverse reaction to Long(R3)-IGF-l is hypoglycemia. Signs of mild to moderate hypoglycemia include hunger, drowsiness, blurred vision, depressive mood, dizziness, sweating, palpitation, tremor, restlessness, tingling in the hands, feet, lips, or tongue, lightheadedness, inability to concentrate, headache, sleep disturbances, anxiety, slurred speech, irritability, abnormal behavior, unsteady movement, and personality changes. If any of these warning signs should occur, one should immediately consume a food or drink containing simple sugars such as a candy bar or carbohydrate drink. Signs of severe hypoglycemia include disorientation, seizure, and unconsciousness. Severe hypoglycemia can lead to death and requires immediate emergency medical attention. Note that in some cases the symptoms of hypoglycemia can be mistaken for drunkenness. Long(R3)-IGF-l should never be taken before sleep or in higher than recommended doses. A meal or snack must be consumed within 20 minutes (before or after) of administration. The subcutaneous administration of Long(R3)-IGF-l may cause redness, itching, or bruising at the site of injection. It may also cause a localized increase of adipose tissue, which may be compounded by the repeated administration at the same site of injection. For these reasons, intramuscular injection is generally preferred with this substance. Other potential adverse reactions to Long(R3)-IGF-l include joint pain, growth of the tonsils, snoring, headache, dizziness, convulsions, vomiting, ear pain, hearing loss, and hypertrophy of the thymus gland. Long(R3)-IGF-l can stimulate the growth of internal organs. Enlargement of the kidney, spleen, and heart were all noted in studies with recombinant IGF-I therapy. Elevations in cholesterol and triglycerides were also observed.The overall relationship between Long(R3)-IGF-I use and cardiac changes remains unclear.Thickening of facial soft tissues is also possible, and should be monitored. The abuse of Long(R3)-IGF-l may cause acromegaly, which is characterized by a visible thickening of the bones, most notably the feet, forehead, hands, jaw, and elbows.

Administration

When used for physique- or performance-enhancing purposes, Long(R3)-IGF-l is primarily given by intramuscular injection. A dosage of 20-80 meg daily is most commonly used. This is given in one application, usually earlier in the day. A meal with sufficient carbohydrate content is consumed within 20 minutes of injection to help reduce the likelihood of hypoglycemia. Long(R3)-IGF-l is often injected into the muscle that will be trained that day, in an effort to support site-specific growth. However, the efficacy of this practice remains unclear. It is generally advised to taper-up the dosage of Long(R3)-IGF-l.The user often begins on the low end of the dosage range (20 meg), and increases the amount by 5-10 meg every 3-4 days, until a desired stable dosage is reached. This practice can help acclimate the user to the effects of Long(R3)-IGF-l, especially its potential blood-sugarlowering properties (see: Side Effects). Cycles of Long(R3)-IGF-l usually last 30-40 days. Beyond this, there is some concern about desensitization to its anabolic effects. After each cycle, a break of at least 4-6 weeks is usually advised. This drug has not been subject to extensive human testing, however. Likewise, its potential for desensitization has not been clearly characterized.
]]> IGF-1 DES — 1mg Insulin-Like Growth Factor-1, DES https://arenismedico.eu/product/igf-1-des-1mg-insulin-like-growth-factor-1-des/ Tue, 12 Jan 2021 21:27:11 +0000 https://arenismedico.eu/?post_type=product&p=558 IGF-1 is a highly anabolic hormone that affects numerous areas of the human body. It also shares an important relationship with Human Growth Hormone (HGH), and on a structural basis is similar to insulin. IGF-1 has been shown to greatly increase the number of cells in the skeletal muscle, which in turn can lead to an enhancement in lean tissue growth. Not only can it promote muscle growth, but by this mode of action can also promote bone growth, and to a degree growth of our internal organs. IGF-1 is also known as a neuroprotector and neuropromotor, which could potentially lead to improved mental function.

Side Effects

Clinical data has shown that more than 40% of all those receiving IGF-1 therapy have experienced hypoglycemia at one level or another. Thankfully, avoiding a hypoglycemic state when using IGF-1 is easy. Before administering your IGF-1 you should consume simple sugars each and every time along with an adequate amount of food, specifically protein and a mixture of simple and complex carbohydrates. This should occur approximately 15-20 minutes before you administer your IGF-1. Once injected, if hypoglycemia symptoms begin to show, immediately consume more simple sugars and continue to consume them until the symptoms go away. If the symptoms of hypoglycemia begin to occur immediately consume fast acting carbohydrates such as candy bars, or any type of sugar filled food or a carbohydrate drink or juice; grape juice is a fantastic choice. If ignored, this can and in many cases will lead to severe hypoglycemia, which has the potential to be fatal. Full blown severe hypoglycemia can lead to severe disorientation, seizure and unconsciousness, but as discussed there is no reason for this to occur if IGF-1 is used properly. Some IGF-1 users may experience joint pain or discomfort despite it typically having a positive impact on joints. Some reports have indicated tonsil growth, which can lead to the individual becoming an extreme snorer. Pronounced organ growth has also been noted in some patients, particularly the kidneys and spleen. IGF-1 can increase cholesterol levels; however, this is very manageable with a healthy diet. The individual’s diet should be rich in omega fatty acids. Daily fish oil supplementation is advised. It is also advised that you incorporate plenty of cardiovascular activity into your daily routine. Some may also find a cholesterol antioxidant supplement to be beneficial. IGF-1 may also thicken facial soft tissue. High doses of the hormone have been linked to facial structure growth, especially in the jaw and forehead with possible growth in the hands, feet and elbows.
]]> IGF-1 is a highly anabolic hormone that affects numerous areas of the human body. It also shares an important relationship with Human Growth Hormone (HGH), and on a structural basis is similar to insulin. IGF-1 has been shown to greatly increase the number of cells in the skeletal muscle, which in turn can lead to an enhancement in lean tissue growth. Not only can it promote muscle growth, but by this mode of action can also promote bone growth, and to a degree growth of our internal organs. IGF-1 is also known as a neuroprotector and neuropromotor, which could potentially lead to improved mental function.

Side Effects

Clinical data has shown that more than 40% of all those receiving IGF-1 therapy have experienced hypoglycemia at one level or another. Thankfully, avoiding a hypoglycemic state when using IGF-1 is easy. Before administering your IGF-1 you should consume simple sugars each and every time along with an adequate amount of food, specifically protein and a mixture of simple and complex carbohydrates. This should occur approximately 15-20 minutes before you administer your IGF-1. Once injected, if hypoglycemia symptoms begin to show, immediately consume more simple sugars and continue to consume them until the symptoms go away. If the symptoms of hypoglycemia begin to occur immediately consume fast acting carbohydrates such as candy bars, or any type of sugar filled food or a carbohydrate drink or juice; grape juice is a fantastic choice. If ignored, this can and in many cases will lead to severe hypoglycemia, which has the potential to be fatal. Full blown severe hypoglycemia can lead to severe disorientation, seizure and unconsciousness, but as discussed there is no reason for this to occur if IGF-1 is used properly. Some IGF-1 users may experience joint pain or discomfort despite it typically having a positive impact on joints. Some reports have indicated tonsil growth, which can lead to the individual becoming an extreme snorer. Pronounced organ growth has also been noted in some patients, particularly the kidneys and spleen. IGF-1 can increase cholesterol levels; however, this is very manageable with a healthy diet. The individual’s diet should be rich in omega fatty acids. Daily fish oil supplementation is advised. It is also advised that you incorporate plenty of cardiovascular activity into your daily routine. Some may also find a cholesterol antioxidant supplement to be beneficial. IGF-1 may also thicken facial soft tissue. High doses of the hormone have been linked to facial structure growth, especially in the jaw and forehead with possible growth in the hands, feet and elbows.
]]> HGH Fragment 176-191 — 5mg Human Growth Hormone Fragment (176-191) https://arenismedico.eu/product/hgh-fragment-176-191-5mg-human-growth-hormone-fragment-176-191/ Tue, 12 Jan 2021 21:25:43 +0000 https://arenismedico.eu/?post_type=product&p=556 HGH Fragment 176-191 is a spliced variant of native human growth hormone. Specifically, it is made of the last 16 amino acids on GH's long 191 amino acid sequence. This fragment seems to retain some (not all) of the biological activity of growth hormone. On the one hand, the compound is no longer able to bind with the cellular GH receptor. As such, it does not elevate serum IGF-1, nor appear to have anabolic effects. On the other, it may still have distinct lipolytic (fat loss) properties. A drug like this could be applicable in situations where fat loss is desired, but GH's wider spectrum of anabolic effects (and potential side effects) is not. In the fitness community, this substance is used exclusively for fat loss.

Side Effects

The most common side effects to HGH Fragment 176-191 include sleepiness and lethargy. Injection site reactions are also highly prominent (See below). Otherwise, the safety and adverse reaction profile of this drug are not fully characterized at this time. The subcutaneous administration of this drug may cause redness, itching, pain, and/or lumps at the site of injection.

Administration

HGH Fragment 176-191 is generally given via subcutaneous (SC) injection. When used for physique-enhancing purposes, HGH Fragment 176-191 is usually administered at a dosage of 0.25 to .5 mg (250-500 meg) per injection. This may be given 1-2 times daily, usually on an empty stomach. One dosing episode is typically 30-60 minutes before cardio training, which may further intensify its fat loss effects. Total daily dosage generally does not exceed 1,000 meg. Cycles of HGH Fragment 176-191 usually last 2-3 months, though longer programs are not uncommon.
]]> HGH Fragment 176-191 is a spliced variant of native human growth hormone. Specifically, it is made of the last 16 amino acids on GH's long 191 amino acid sequence. This fragment seems to retain some (not all) of the biological activity of growth hormone. On the one hand, the compound is no longer able to bind with the cellular GH receptor. As such, it does not elevate serum IGF-1, nor appear to have anabolic effects. On the other, it may still have distinct lipolytic (fat loss) properties. A drug like this could be applicable in situations where fat loss is desired, but GH's wider spectrum of anabolic effects (and potential side effects) is not. In the fitness community, this substance is used exclusively for fat loss.

Side Effects

The most common side effects to HGH Fragment 176-191 include sleepiness and lethargy. Injection site reactions are also highly prominent (See below). Otherwise, the safety and adverse reaction profile of this drug are not fully characterized at this time. The subcutaneous administration of this drug may cause redness, itching, pain, and/or lumps at the site of injection.

Administration

HGH Fragment 176-191 is generally given via subcutaneous (SC) injection. When used for physique-enhancing purposes, HGH Fragment 176-191 is usually administered at a dosage of 0.25 to .5 mg (250-500 meg) per injection. This may be given 1-2 times daily, usually on an empty stomach. One dosing episode is typically 30-60 minutes before cardio training, which may further intensify its fat loss effects. Total daily dosage generally does not exceed 1,000 meg. Cycles of HGH Fragment 176-191 usually last 2-3 months, though longer programs are not uncommon.
]]>